Skip to content

Tradipitant

DRUG17 trials

Sponsors

Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals, Xiao Jing (Iris) Wang

Conditions

Atopic DermatitisCoronavirus InfectionDiabetic GastroparesisFunctional DyspepsiaGastroparesisHealthy VolunteerHealthy VolunteersIdiopathic Gastroparesis

Phase 1

Phase 2

Phase 3

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
CompletedNCT03568331
Vanda PharmaceuticalsAtopic Dermatitis
Start: 2018-07-09End: 2019-12-27Updated: 2024-05-13
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
CompletedNCT04028492
Vanda PharmaceuticalsDiabetic Gastroparesis, Gastroparesis, Idiopathic Gastroparesis
Start: 2019-08-20End: 2025-02-21Updated: 2025-07-24
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
TerminatedNCT04140695
Vanda PharmaceuticalsAtopic Dermatitis
Start: 2019-10-21End: 2020-10-14Updated: 2024-05-14
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
Enrolling by invitationNCT04326426
Vanda PharmaceuticalsCoronavirus Infection
Start: 2020-04-13End: 2020-08-31Target: 300Updated: 2020-04-20
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
CompletedNCT04327661
Vanda PharmaceuticalsMotion Sickness
Start: 2021-11-15End: 2023-04-12Updated: 2024-12-11
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
CompletedNCT05903924
Vanda PharmaceuticalsMotion Sickness
Start: 2023-09-09End: 2024-04-24Updated: 2025-04-04
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Active, not recruitingNCT06138613
Vanda PharmaceuticalsMotion Sickness
Start: 2023-02-27End: 2027-12-30Updated: 2026-04-16
A MULTICENTER OPEN LABEL 3 MONTH SAFETY STUDY WITH TRADIPITANT IN PATIENTS WITH IDIOPATHIC OR DIABETIC GASTROPARESIS
RecruitingCTIS2023-503802-35-00
Vanda Pharmaceuticals Inc.Idiopathic or diabetic gastroparesis with moderate to severe nausea.
Start: 2023-11-29Target: 70Updated: 2025-11-13
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
RecruitingNCT06836557
Vanda PharmaceuticalsDiabetic Gastroparesis, Gastroparesis, Idiopathic Gastroparesis
Start: 2024-01-09End: 2025-12-31Target: 100Updated: 2025-02-20
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
RecruitingNCT07446439
Vanda PharmaceuticalsNausea and Vomiting, Obesity
Start: 2026-03-27End: 2026-12-01Target: 280Updated: 2026-04-20

Unknown Phase

Related Papers